To see or not A1c? HbA1c utilization in light of recent lab guidelines

Jul. 12, 2024

Educational Webinar with Dr. Matthew C. Wagner

Unlocking the power of anti-MCV detection for early diagnosis of Rheumatoid Arthritis

Jun. 07, 2024

Educational Webinar with Holger Bang, PhD & Roberto Fiorillo

May. 17, 2024 May. 20, 2024

Ljubljana, Slovenia

14th International Congress on Autoimmunity 2024

Sebia booth #15

Learn more

Sebia receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devices

Press release
Apr. 11, 2024

The next generation instrument for screening hemoglobin disorders in newborns.

Our complete product range


From the lowest to the highest volumes, with standalone instruments, workcell configurations or directly integrated into lab track automation, Sebia will provide the right solution for each laboratory.

See all our instruments


From multiple myeloma to metabolic disorders, hemoglobinopathies and genetic diseases, Sebia’s portfolio is designed to address clinical needs and improve laboratory efficiency and safety.

See all our tests

Our solutions tailored for your needs


The networked expert companion of all Sebia instruments.


Sebia Lean Service

With a modular and scalable offer, Sebia Lean Service is designed to enhance the laboratory performance with customized product and management solutions.

Learn more

Sebia Academy

We aim to educate and share scientific and medical educational information with our customers all around the world.

Learn more

Sebia Service

We offer daily assistance for technical and scientific matters.

Learn more

Our key figures

+20 000
installed instruments worldwide
countries covered
+1 000
employees worldwide
Sebia Capillary Electrophoresis Protein tests performed in the world from Jan 1st, 2022

Create your free account MySebia

Customize your viewing experience
Get access to exclusive events near you
Bookmark and keep all your resources in one place
Subscribe to specific newsletters and content